Furthermore, our clinical data analysis showed that both GABAA receptors (GABRA3) and GABAB receptor (GABBR2) genes were significantly expressed in the early pathological stage (stage I and II) of the lung cancer patients, and the expression was gone in stage III and IV. Here, GABRA3 is linked to lung carcinoma.